Reprint

Tea in Health and Disease

Edited by
May 2019
222 pages
  • ISBN978-3-03897-986-9 (Paperback)
  • ISBN978-3-03897-987-6 (PDF)

This is a Reprint of the Special Issue Tea in Health and Disease that was published in

Medicine & Pharmacology
Public Health & Healthcare
Summary

Tea, made from the leaves of the Camellia senenisis plant, is the second most consumed beverage worldwide after water. Accumulating evidence from cellular, animal, epidemiological and clinical studies have linked tea consumption to various health benefits, such as chemoprevention of cancers, chronic inflammation, heart and liver diseases, diabetes, neurodegenerative diseases, etc. Although such health benefits have not been consistently observed in some intervention trials, positive results from clinical trials have provided direct evidence supporting the cancer-protective effect of green tea. In addition, numerous mechanisms of action have been suggested to contribute to tea’s disease-preventive effects. Furthermore, effects of the processing and storage of tea, as well as additives on tea’s properties have been investigated.

Related Books

February 2025

Advances in Tea Chemistry

Biology & Life Sciences
October 2022

Coffee and Caffeine Consumption for Human Health

Biology & Life Sciences
...
January 2022

Effect of Phenolic Compounds on Human Health

Biology & Life Sciences
December 2020

Dietary Polyphenols and Human Health

Public Health & Healthcare
September 2023

Health Promoting Effects of Phytochemicals

Biology & Life Sciences

The recommendations have been generated using an AI system.